Committee Members
Past Committee Members
FENS Structure
FENS is governed by a Council. Each member society has one vote in the Council. >>

.: Thermos, Kyriaki (Kiki)

Publication Committee Member

Kyriaki (Kiki) Thermos
University of Crete
Faculty of Medicine
Department of Basic Science
Laboratory of Pharmacology
Heraklion, Crete 71500
Greece
Phone: +30 2810 394533
Fax: +30 2810 394530
E-mail: thermos@med.uoc.gr

Curriculum Vitae

Research interests

Ischemia induced retinal neurodegeneration; Animal Models of Retinopathies Neuroprotection; Neurotransmission, Neuropeptides

Education

1976
BSc, University of Patras, Dept Chemistry (Patras, Greece)
1979
MSc, New York University, Dept of Chemistry (New York, USA)
1984
PhD, New York University, Dept of Chemistry (New York, USA)
1984-1986
Post-doc, Neuropsychopharmacology Training Program University of Pennsylvania, School of Medicine, Depts Psychiatry/Pharmacology Medical College of Pennsylvania, Pharmacology (Philadelphia, USA)
1986-1988
Post-doc, University of Pennsylvania School of Medicine, Dept of Pharmacology (Philadelphia, USA)

Positions

1988-1993
Assistant Professor of Pharmacology University of Crete, Faculty of Medicine (Heraklion, Crete, Greece)
1993-2009
Associate Professor of Pharmacology University of Crete, Faculty of Medicine (Heraklion, Crete, Greece)
2009-present
Professor of Pharmacology University of Crete, Faculty of Medicine (Heraklion, Crete, Greece)

Professional Memberships

1980-present
American Society for Neuroscience
1989-present
European Neuroscience Association/FENS
1989-present
Hellenic Society for Neuroscience
1988-present
Greek Pharmacology Society

Academic Services to Societies

1989-1992
Member, Executive Council, Hellenic Society for Neuroscience
2000-2006
Member, IBRO Governing Council
2001-2003
President, Greek Pharmacology Society
2003-2005
General Secretary, Greek Pharmacology Society
2003-2005
Member, Network of European Neuroscience Schools (NENS)

Selected Publications

  • Kiagiadaki, F., Savvaki, M., Thermos, K. Activation of somatostatin receptor (sst5) protects the rat retina from AMPA-induced neurotoxicity. Neuropharmacology 58:297-303, 2010
  • Vasilaki A, Thermos K. Somatostatin analogues as therapeutics in retinal disease. Pharmacol Therapeutics 122:324-333, 2009
  • Thermos, K. Novel signals mediating the function of somatostatin: the emerging role of NO/cGMP. Molecular and Cellular Endocrinology (Special Issue on Somatostatin and Cortistatin) 286: 49-57, 2008
  • Kiagadaki, F. and Thermos, K. Intravitreal administration of somatostatin and sst2 analogs protect the rat retina from AMPA-induced neurotoxicity. Investigative Ophthalmology Visual Science 49:3080-3089, 2008
  • Mastrodimou, N., Kiagiadaki, F., Thermos, K. The role of nitric oxide and cGMP in somatostatin?s protection of retinal ischemia. Investigative Ophthalmology Visual Science 49: 342-249, 2008
  • Kiagiadaki, F., Koulakis, E., Thermos , K. Dopamine via D1 receptor activation and cGMP modulate somatostatin release in the rat retina. Experimental Eye Research 86:18-24, 2008
  • Thermos, K., Bagnoli, P., Epelbaum, J., Hoyer, D. The somatostatin sst1 receptor: An autoreceptor for somatostatin in brain and retina? Pharmacology and Therapeutics 110: 455-464, 2006
  • Mastrodimou, N., Vasilaki, A., Papadioti, A., Low, M., Hoyer, D. and Thermos, K. Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology. Neuropeptides, 40:365-373, 2006
  • Mastrodimou, N., Lambrou, G., and Thermos, K. Effect of somatostatin, cortistatin and sst2 agonists on chemically induced ischemia in rat retina. Naunyn-Schmiedeberg?s Archives of Pharmacology 371: 44-53, 2005
  • Vasilaki, A., Papadaki, T., Notas, G., Kolios, G., Mastrodimou, N., Hoyer, D, Tsilimbaris, M., Kouroumalis, E., Pallikaris, I. and Thermos, K. Somatostatin regulates nitric oxide production in human retinal pigment epithelium (RPE) cell cultures Investigative Ophthalmology + Visual Science 45:1499-506, 2004
  • Vasilaki, ?., Papasava, D., Hoyer, D., and Thermos, K. Somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens. Neuropharmacology 47: 612-618, 2004
  • Vasilaki, A., Georgousi, Z., and Thermos, K. Somatostatin receptors (sst2) are coupled to Go and modulate GTPase activity in the rabbit retina. Journal of Neurochemistry 84:625-632, 2003
  • Thermos K. Functional mapping of somatostatin receptors in the retina: A review Vision Research 43: 1805-1815, 2003
  • Papadaki, T, Tsilibaris, M., Thermos, K., Karavellas, M.P., Samonakis, D., Papadakis, A., Linardakis, M., Pallikaris, I. The role of lanreotide in the treatment of choroidal neovascularization secondary to age related macular degeneration: a pilot clinical study Retina 26: 800-807, 2003
  • Vasilaki, A., Mouratidou, M., Schulz, S., Thermos, K. Somatostatin influences nitric oxide production in the rat retina. Neuropharmacology 43: 899-909, 2002
  • Vasilaki, A., Gardette, R., Epelbaum, J. and Thermos, K. NADPH-diaphorase colocalizes with somatostatin receptor subtypes sst2A and sst2B in the rat and rabbit retina. Investigative Ophthalmology and Visual Science 42: 1600-1609, 2001